Cite

[Standardized determination of tumor-infiltrating lymphocytes in breast cancer : A prognostic marker for histological diagnosis].

MLA

Denkert, C., et al. “[Standardized Determination of Tumor-Infiltrating Lymphocytes in Breast Cancer : A Prognostic Marker for Histological Diagnosis].” Der Pathologe, vol. 39, no. 6, Nov. 2018, pp. 520–31. EBSCOhost, https://doi.org/10.1007/s00292-018-0530-y.



APA

Denkert, C., Loibl, S., Budczies, J., Wienert, S., & Klauschen, F. (2018). [Standardized determination of tumor-infiltrating lymphocytes in breast cancer : A prognostic marker for histological diagnosis]. Der Pathologe, 39(6), 520–531. https://doi.org/10.1007/s00292-018-0530-y



Chicago

Denkert, C, S Loibl, J Budczies, S Wienert, and F Klauschen. 2018. “[Standardized Determination of Tumor-Infiltrating Lymphocytes in Breast Cancer : A Prognostic Marker for Histological Diagnosis].” Der Pathologe 39 (6): 520–31. doi:10.1007/s00292-018-0530-y.